Loading clinical trials...
Loading clinical trials...
A Scandinavian, Randomized, Rater-blinded Study of Single and Double-dose Betaferon in Patients With Early Secondary Progressive Multiple Sclerosis
Conditions
Interventions
Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
Locations
7
Denmark
Ask Contact, Denmark
Copenhagen, Denmark
Hillerød, Denmark
Holstebro, Denmark
Stockholm, Sweden
Stockholm, Sweden
Last Updated
March 10, 2015
NCT07225504
NCT06276634
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions